ZBIO
Zenas BioPharma, Inc.
NASDAQ · Healthcare · Biotechnology · US
$28.46
+0.28%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 32.73x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 7.51x
- Price / sales
- 1854.93x
- Price / cash flow
- -8.21x
Enterprise value
- Enterprise value
- $1.6B
- EV / sales
- 1601.40x
- EV / EBITDA
- -3.50x
- EV / EBIT
- -3.37x
- Market cap
- $1.9B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026